There are some risk factors related to the appearance of ARs during immunotherapy, which are the following [5,14]: hypertension, mastocytosis, β-blockers/ACE inhibitors intake, serum basal tryptase concentration, male sex, old age, etc. [13,29]. This evidence concerns the gene ACE and Axenfeld-Rieger syndrome.